Form 8-K - Current report:
SEC Accession No. 0001104659-24-093434
Filing Date
2024-08-27
Accepted
2024-08-27 16:16:05
Documents
14
Period of Report
2024-08-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2422732d1_8k.htm   iXBRL 8-K 33785
  Complete submission text file 0001104659-24-093434.txt   260693

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gpcr-20240824.xsd EX-101.SCH 3893
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gpcr-20240824_def.xml EX-101.DEF 27150
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gpcr-20240824_lab.xml EX-101.LAB 37087
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gpcr-20240824_pre.xml EX-101.PRE 25774
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2422732d1_8k_htm.xml XML 6191
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41608 | Film No.: 241249210
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)